C-Reactive Protein Testing Market Share, Size, Trends, Industry Analysis Report, By Assay Type (Immuno-turbidimetric Assay, ELISA, Chemiluminescence Immunoassay); By Detection Range; By Disease Area; By End-Use; By Region; Segment Forecast, 2022 - 2029
The global c-reactive protein testing market size is expected to reach USD 2,158.62 million by 2029 according to a new study by Polaris Market Research. The report “C-Reactive Protein Testing Market Share, Size, Trends, Industry Analysis Report, By Assay Type (Immuno-turbidimetric Assay, ELISA, Chemiluminescence Immunoassay); By Detection Range; By Disease Area; By End-Use; By Region; Segment Forecast, 2022 – 2029” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Increasing heart-related diseases due to the increasing geriatric population, obesity, and others are expected to increase the demand for the industry over the forecast period. Additionally, rising awareness for preventing and treating cardiovascular diseases, along with increasing investments for novel techniques, are expected to propel the industry over the forecast period.
Furthermore, the ongoing COVID-19 pandemic has increased the demand for innovative diagnosis with rapid results, has increased the demand for point-of-care testing, which in turn has benefited the industry and is expected to increase over the forecast period.
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global C-reactive protein Testing Market Insights
- 4.1. C-reactive protein Testing – Industry Snapshot
- 4.2. C-reactive protein Testing Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.2. Restraints and Challenges
- 4.2.3. Porter’s Five Forces Analysis
- 4.2.3.1. Bargaining Power of Suppliers (Moderate)
- 4.2.3.2. Threats of New Entrants: (Low)
- 4.2.3.3. Bargaining Power of Buyers (Moderate)
- 4.2.3.4. Threat of Substitute (Moderate)
- 4.2.3.5. Rivalry among existing firms (High)
- 4.2.4. PESTLE Analysis
- 4.2.5. C-reactive protein Testing Industry Trends
- 4.2.6. COVID-19 Impact Analysis
- 5. Global C-reactive protein Testing Market, by Assay Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 5.3. Immuno-turbidimetric Assay
- 5.3.1. Global C-reactive protein Testing Market, by Immuno-turbidimetric Assay, by Region, 2017 - 2029 (USD Million)
- 5.4. ELISA
- 5.4.1. Global C-reactive protein Testing Market, by ELISA, by Region, 2017 - 2029 (USD Million)
- 5.4.2. Clinical
- 5.4.2.1. Global C-reactive protein Testing Market, by Clinical, by Region, 2017 - 2029 (USD Million)
- 5.4.3. Non-clinical
- 5.4.3.1. Global C-reactive protein Testing Market, by Non-clinical, by Region, 2017 - 2029 (USD Million)
- 5.5. Chemiluminescence Immunoassay
- 5.5.1. Global C-reactive protein Testing Market, by Chemiluminescence Immunoassay, by Region, 2017 - 2029 (USD Million)
- 5.6. Others
- 5.6.1. Global C-reactive protein Testing Market, by Others, by Region, 2017 - 2029 (USD Million)
- 6. Global C-reactive protein Testing Market, by Detection Range
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 6.3. hs-CRP
- 6.3.1. Global C-reactive protein Testing Market, by hs-CRP, by Region, 2017 - 2029 (USD Million)
- 6.4. Conventional CRP
- 6.4.1. Global C-reactive protein Testing Market, by Conventional CRP, by Region, 2017 - 2029 (USD Million)
- 6.5. cCRP
- 6.5.1. Global C-reactive protein Testing Market, by cCRP, by Region, 2017 - 2029 (USD Million)
- 7. Global C-reactive protein Testing Market, by Disease Area
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 7.3. Cardiovascular Diseases
- 7.3.1. Global C-reactive protein Testing Market, by Cardiovascular Diseases, By Region, 2017 - 2029 (USD Million)
- 7.4. Cancer
- 7.4.1. Global C-reactive protein Testing Market, by Cancer, By Region, 2017 - 2029 (USD Million)
- 7.5. Rheumatoid Arthritis
- 7.5.1. Global C-reactive protein Testing Market, by Rheumatoid Arthritis, By Region, 2017 - 2029 (USD Million)
- 7.6. Inflammatory Bowel Disease
- 7.6.1. Global C-reactive protein Testing Market, by Inflammatory Bowel Disease, By Region, 2017 - 2029 (USD Million)
- 7.7. Endometriosis
- 7.7.1. Global C-reactive protein Testing Market, by Endometriosis, By Region, 2017 - 2029 (USD Million)
- 7.8. Lupus
- 7.8.1. Global C-reactive protein Testing Market, by Lupus, By Region, 2017 - 2029 (USD Million)
- 8. Global C-reactive protein Testing Market, by End-Use
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 8.3. Clinics
- 8.3.1. Global C-reactive protein Testing Market, By Clinics, By Region, 2017 - 2029 (USD Million)
- 8.4. Hospitals
- 8.4.1. Global C-reactive protein Testing Market, by Hospitals, by Region, 2017 - 2029 (USD Million)
- 8.5. Laboratories
- 8.5.1. Global C-reactive protein Testing Market, by Laboratories, by Region, 2017 - 2029 (USD Million)
- 8.6. Assisted Living Healthcare Facilities
- 8.6.1. Global C-reactive protein Testing Market, by Assisted Living Healthcare Facilities, by Region, 2017 - 2029 (USD Million)
- 8.7. Home Care Settings
- 8.7.1. Global C-reactive protein Testing Market, by Home Care Settings, by Region, 2017 - 2029 (USD Million)
- 8.8. Others
- 8.8.1. Global C-reactive protein Testing Market, by Others, by Region, 2017 - 2029 (USD Million)
- 9. Global C-reactive protein Testing Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. C-reactive protein Testing Market Assessment, By Geography, 2017 - 2029 (USD Million)
- 9.3. C-reactive protein Testing Market – North America
- 9.3.1. North America: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.3.2. North America: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.3.3. North America: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.3.4. North America: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.3.5. C-reactive protein Testing Market – U.S.
- 9.3.5.1. U.S.: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.3.5.2. U.S.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.3.5.3. U.S.: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.3.5.4. U.S.: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.3.6. C-reactive protein Testing Market – Canada
- 9.3.6.1. Canada: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.3.6.2. Canada.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.3.6.3. Canada: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.3.6.4. Canada: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.4. C-reactive protein Testing Market – Europe
- 9.4.1. Europe: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.4.2. Europe.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.4.3. Europe: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.4.4. Europe: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.4.5. C-reactive protein Testing Market – UK
- 9.4.5.1. UK: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.4.5.2. UK.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.4.5.3. UK: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.4.5.4. UK: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.4.6. C-reactive protein Testing Market – France
- 9.4.6.1. France: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.4.6.2. France.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.4.6.3. France: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.4.6.4. France: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.4.7. C-reactive protein Testing Market – Germany
- 9.4.7.1. Germany: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.4.7.2. Germany.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.4.7.3. Germany: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.4.7.4. Germany: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.4.8. C-reactive protein Testing Market – Italy
- 9.4.8.1. Italy: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.4.8.2. Italy.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.4.8.3. Italy: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.4.8.4. Italy: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.4.9. C-reactive protein Testing Market – Spain
- 9.4.9.1. Spain: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.4.9.2. Spain.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.4.9.3. Spain: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.4.9.4. Spain: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.4.10. C-reactive protein Testing Market – Netherlands
- 9.4.10.1. Netherlands: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.4.10.2. Netherlands.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.4.10.3. Netherlands: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.4.10.4. Netherlands: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.4.11. C-reactive protein Testing Market – Austria
- 9.4.11.1. Austria: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.4.11.2. Austria.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.4.11.3. Austria: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.4.11.4. Austria: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.5. C-reactive protein Testing Market – Asia Pacific
- 9.5.1. Asia Pacific: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.5.2. Asia Pacific.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.5.3. Asia pacific: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.5.4. Asia pacific: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.5.5. C-reactive protein Testing Market – China
- 9.5.5.1. China: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.5.5.2. China.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.5.5.3. China: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.5.5.4. China: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.5.6. C-reactive protein Testing Market – India
- 9.5.6.1. India: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.5.6.2. India.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.5.6.3. India: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.5.6.4. India: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.5.7. C-reactive protein Testing Market – Malaysia
- 9.5.7.1. Malaysia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.5.7.2. Malaysia.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.5.7.3. Malaysia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.5.7.4. Malaysia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.5.8. C-reactive protein Testing Market – Japan
- 9.5.8.1. Japan: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.5.8.2. Japan.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.5.8.3. Japan: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.5.8.4. Japan: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.5.9. C-reactive protein Testing Market – Indonesia
- 9.5.9.1. Indonesia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.5.9.2. Indonesia.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.5.9.3. Indonesia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.5.9.4. Indonesia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.5.10. C-reactive protein Testing Market – South Korea
- 9.5.10.1. South Korea: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.5.10.2. South Korea.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.5.10.3. South Korea: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.5.10.4. South Korea: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.6. C-reactive protein Testing Market – Middle East & Africa
- 9.6.1. Middle East & Africa: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.6.2. Middle East & Africa.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.6.3. Middle East & Africa: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.6.4. Middle East & Africa: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.6.5. C-reactive protein Testing Market – Saudi Arabia
- 9.6.5.1. Saudi Arabia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.6.5.2. Saudi Arabia.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.6.5.3. Saudi Arabia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.6.5.4. Saudi Arabia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.6.6. C-reactive protein Testing Market – UAE
- 9.6.6.1. UAE: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.6.6.2. UAE.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.6.6.3. UAE: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.6.6.4. UAE: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.6.7. C-reactive protein Testing Market – Israel
- 9.6.7.1. Israel: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.6.7.2. Israel.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.6.7.3. Israel: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.6.7.4. Israel: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.6.8. C-reactive protein Testing Market – South Africa
- 9.6.8.1. South Africa: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.6.8.2. South Africa.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.6.8.3. South Africa: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.6.8.4. South Africa: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.7. C-reactive protein Testing Market – Latin America
- 9.7.1. Latin America: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.7.2. Latin America.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.7.3. Latin America: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.7.4. Latin America: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.7.5. C-reactive protein Testing Market – Mexico
- 9.7.5.1. Mexico: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.7.5.2. Mexico.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.7.5.3. Mexico: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.7.5.4. Mexico: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.7.6. C-reactive protein Testing Market – Brazil
- 9.7.6.1. Brazil: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.7.6.2. Brazil.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.7.6.3. Brazil: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.7.6.4. Brazil: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 9.7.7. C-reactive protein Testing Market – Argentina
- 9.7.7.1. Argentina: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
- 9.7.7.2. Argentina.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
- 9.7.7.3. Argentina: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
- 9.7.7.4. Argentina: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
- 10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
- 11. Company Profiles
- 11.1. Abaxis, Inc.
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Abbott
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Aidian
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. BODITECH MED, INC
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Danaher
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. F. Hoffmann-La Roche Ltd.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Getein Biotech, Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. HORIBA, Ltd.
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Laboratory Corporation of America Holdings
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Merck KGaA
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Ortho Clinical Diagnostics
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Quest Diagnostics
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
- 11.13. Randox Laboratories Ltd.
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
- 11.14. Roche Ltd.
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
- 11.15. Siemens Healthineers AG
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development
- 11.16. Thermo Fisher Scientific, Inc.
- 11.16.1. Company Overview
- 11.16.2. Financial Performance
- 11.16.3. Product Benchmarking
- 11.16.4. Recent Development
- 11.17. Zoetis
- 11.17.1. Company Overview
- 11.17.2. Financial Performance
- 11.17.3. Product Benchmarking
- 11.17.4. Recent Development
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook